Schemmerer, Mathias and Pfluger, Lisa Sophie and Schneider, Tanja and Lu, Jie and Kienle, Korbinian and Meyer-schlinkmann, Kristin Maria and Muhlbacher, Annelies and Polz, Johannes and Schennach, Harald and Xie, Qing and Voitenleitner, Christian and Wenzel, Jürgen J. and Lutgehetmann, Marc (2025) Performance of Elecsys Anti-HEV IgG and IgM Assays for the Detection of Acute, Recent or Past Hepatitis E Virus Infection. LIVER INTERNATIONAL, 46 (1): e70480. ISSN 1478-3223, 1478-3231
Full text not available from this repository. (Request a copy)Abstract
Background & Aims: Hepatitis E virus (HEV) is the leading cause of acute viral hepatitis. We evaluated the performance of the new automated Elecsys Anti-HEV IgG and Elecsys Anti-HEV IgM assays (Roche Diagnostics) in detecting acute, recent and past HEV infection. Methods: Performance of the Elecsys assays relative to three commercially available CE-IVD anti-HEV assays was assessed in a large multinational cohort (six laboratories in Germany, Austria and China). Sensitivity testing included samples from patients with presumed acute (IgM: n = 707; IgG: n = 490) and recovered HEV infection (n = 156). Specificity testing included samples from asymptomatic blood donors (n = 5040), routine diagnostic samples (n = 2427), and pregnant women (n = 544). An in-house anti-HEV IgG neutralisation method was performed to resolve discrepant specificity sample results. Seroconversion sensitivity analysis was performed using nine commercial seroconversion panels (n = 119 samples). Results: Relative sensitivity and specificity of the Elecsys assays were > 98.6% (95% CI: 92.2%-100%) and > 98.9% (98.4%-99.2%) for anti-HEV IgM and > 81.2% (79.3%-83.0%) for anti-HEV IgG in different cohorts, respectively. After confirming anti-HEV IgG in 680/696 discrepant samples by a neutralisation method, relative specificity of the Elecsys Anti-HEV IgG assay was > 99.4% (98.8%-99.7%). Evaluation of commercial seroconversion panels showed good overall agreement between the assays. Conclusions: The Elecsys Anti-HEV IgG and IgM assays showed favourable overall performance when compared to three commercially available CE-IVD marked assays. Neutralisation data indicated higher sensitivity of the Elecsys Anti-HEV IgG assay than comparator assays in detecting past infections and lower IgG concentrations.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | ; blood donors; hepatitis antibodies; hepatitis E virus; seroconversion; viremia |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Medizinische Mikrobiologie und Hygiene |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 23 Apr 2026 09:52 |
| Last Modified: | 23 Apr 2026 09:52 |
| URI: | https://pred.uni-regensburg.de/id/eprint/67575 |
Actions (login required)
 |
View Item |
